BRPI0921414A2 - isolated mesenchymal stem cell population, pharmaceutical composition, and method for isolating a myometrial tissue stem cell population. - Google Patents

isolated mesenchymal stem cell population, pharmaceutical composition, and method for isolating a myometrial tissue stem cell population.

Info

Publication number
BRPI0921414A2
BRPI0921414A2 BRPI0921414A BRPI0921414A BRPI0921414A2 BR PI0921414 A2 BRPI0921414 A2 BR PI0921414A2 BR PI0921414 A BRPI0921414 A BR PI0921414A BR PI0921414 A BRPI0921414 A BR PI0921414A BR PI0921414 A2 BRPI0921414 A2 BR PI0921414A2
Authority
BR
Brazil
Prior art keywords
stem cell
cell population
isolating
pharmaceutical composition
isolated mesenchymal
Prior art date
Application number
BRPI0921414A
Other languages
Portuguese (pt)
Inventor
Gálvez Beatriz González
Cimadevilla Rodríguez
Original Assignee
Manuel Diaz Arroyo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Manuel Diaz Arroyo filed Critical Manuel Diaz Arroyo
Publication of BRPI0921414A2 publication Critical patent/BRPI0921414A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI0921414A 2008-11-20 2009-11-20 isolated mesenchymal stem cell population, pharmaceutical composition, and method for isolating a myometrial tissue stem cell population. BRPI0921414A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08380324 2008-11-20
PCT/EP2009/065523 WO2010057965A1 (en) 2008-11-20 2009-11-20 Myometrial-derived mesenchymal stem cells

Publications (1)

Publication Number Publication Date
BRPI0921414A2 true BRPI0921414A2 (en) 2019-09-24

Family

ID=41503587

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0921414A BRPI0921414A2 (en) 2008-11-20 2009-11-20 isolated mesenchymal stem cell population, pharmaceutical composition, and method for isolating a myometrial tissue stem cell population.

Country Status (6)

Country Link
EP (1) EP2366023A1 (en)
JP (1) JP2012509074A (en)
AU (1) AU2009317191A1 (en)
BR (1) BRPI0921414A2 (en)
CA (1) CA2744423A1 (en)
WO (1) WO2010057965A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2558570A1 (en) * 2009-10-08 2013-02-20 Fundacion Para La Investigacion De Celulas Madre Uterinas (Ficemu) Myometrial-derived mesenchymal stem cells and uses thereof
BR112013004917A2 (en) * 2010-08-31 2016-09-20 Cook General Biotechnology Llc systemic allogeneic stem cell therapies for treating diseases in animals.
WO2016044421A1 (en) * 2014-09-18 2016-03-24 National Health Research Institutes Progenitor cells, method for preparation thereof and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1876233A1 (en) * 2005-01-24 2008-01-09 Japan Health Sciences Foundation Cells capable of differentiating into cardiac muscle cells
US20090053182A1 (en) * 2007-05-25 2009-02-26 Medistem Laboratories, Inc. Endometrial stem cells and methods of making and using same

Also Published As

Publication number Publication date
WO2010057965A1 (en) 2010-05-27
CA2744423A1 (en) 2010-05-27
AU2009317191A1 (en) 2011-06-30
JP2012509074A (en) 2012-04-19
EP2366023A1 (en) 2011-09-21

Similar Documents

Publication Publication Date Title
BRPI0819936A2 (en) Pharmaceutical preparation, method for producing dendritic cells, dendritic cells, pharmaceutical composition, and use of a dendritic cell or preparation.
BRPI0922345A2 (en) Compound, method for stabilizing an isolated cell in vitro, for improving a condition in an animal, and for maintaining and surviving stem cell, and, isolated cell population
BRPI1010775A2 (en) composition, method for preparing a composition, and use of a composition.
BRPI0716439A2 (en) flibanserine formulations and method for their manufacture.
BRPI1011764A2 (en) pharmaceutical composition and method for preparing a pharmaceutical composition
BRPI0916689A2 (en) stabilized pharmaceutical composition, solid preparation, and methods for stabilizing a pharmaceutical composition, and for stabilizing a solid preparation.
BR112012009609A2 (en) method for making a solid dispersion, solid dispersion, pharmaceutical preparation and compositions
BRPI0819218A2 (en) Methods, kits and compositions for administering pharmaceutical compounds
BRPI1015979A8 (en) Hemostatic porous sponge and method for making a hemostatic porous sponge
BRPI0912384A2 (en) composition and method for preparing a composition
BRPI0924664A2 (en) electrode, and method for constructing an electrode.
BRPI1009981A2 (en) systems, methods and compositions for optimizing tissue and cell enriched grafts
BRPI0807220B1 (en) and methods for increasing the compressive strength of a composition and for increasing fragrance retention of a composition
BRPI0908092A2 (en) Sweetener, method for preparing a sweetener composition, and, sweetener composition
BRPI0914918A2 (en) pharmaceutical dosage form, and method for preparing a solid dosage form.
BRPI1011423A2 (en) injectable composition, kit and cosmetic method.
BRPI1007266A2 (en) apparatus and methods for separating, and for separating and transferring tablets.
BRPI0716048A2 (en) battery and method for manufacturing a cathode for a battery.
BRPI0719272A2 (en) ENZYME COMPOSITION, AND METHOD FOR PREPARING AN ENZYME COMPOSITION.
BRPI1016132A2 (en) composition, pharmaceutical formulation, method for manufacturing a stable pharmaceutical formulation.
BRPI0822750A2 (en) Oral care implement and method for marketing an oral care implement and faceplate.
BRPI0921220A2 (en) pharmaceutical dispenser cartridge for solid pharmaceutical portions as well as cartridge and pharmaceutical dispenser jobs.
BRPI0905369A2 (en) Pharmaceutical composition, composition and compartmentalized kit
BRPI1014035A2 (en) method for contraception.
BRPI1011264A2 (en) method for manufacturing a solid electrolyte battery, and, solid electrolyte battery.

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.